Ligand Pharmaceuticals (LGND)

AI Score

Unlock

108.09

-0.46 (-0.42%)

At close: Apr 25, 2025, 3:59 PM

107.15

-0.87%

After-hours: Apr 25, 2025, 05:54 PM EDT

Ligand Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	167.13M	131.31M	196.25M	277.13M	186.42M	120.28M	251.45M	141.1M	108.97M
Cost of Revenue	11.07M	35.05M	52.83M	62.18M	30.42M	11.35M	6.34M	5.37M	5.57M
Gross Profit	156.06M	96.27M	143.42M	214.96M	156M	108.94M	245.12M	135.74M	103.4M
Operating Income	-22.61M	11.94M	-25.5M	78.89M	8.55M	-5.72M	163.73M	68.08M	43.88M
Interest Income	8.05M	7.71M	2.05M	886K	8.08M	28.43M	14M	n/a	n/a
Pretax Income	2.52M	63.66M	36.01M	47.3M	-10.54M	796.64M	173.33M	57.23M	7.96M
Net Income	-4.03M	52.15M	-5.22M	57.14M	-2.98M	629.3M	143.32M	12.56M	-1.64M
Selling & General & Admin	78.65M	52.79M	70.06M	57.48M	64.44M	41.88M	37.73M	28.65M	26.62M
Research & Development	21.43M	24.54M	36.08M	69.01M	59.39M	55.91M	27.86M	26.89M	21.22M
Other Expenses	78.59M	7M	34.24M	9.57M	23.44M	16.86M	15.79M	12.12M	10.64M
Operating Expenses	178.66M	84.32M	140.38M	136.06M	147.27M	114.66M	81.39M	67.66M	58.48M
Interest Expense	3.04M	656K	1.8M	18.74M	27.42M	35.74M	48.28M	11.4M	12.18M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	189.74M	119.37M	193.21M	198.24M	177.69M	126M	87.73M	73.03M	64.06M
Income Tax Expense	-6.55M	9.84M	41.23M	-10.29M	-7.55M	167.34M	30.01M	44.67M	10.33M
Shares Outstanding (Basic)	18.29M	17.3M	16.87M	16.63M	16.18M	19M	24.05M	21.03M	20.83M
Shares Outstanding (Diluted)	18.29M	17.76M	16.87M	17.25M	16.18M	19.76M	24.07M	23.48M	20.83M
EPS (Basic)	-0.22	3.02	-0.31	3.44	-0.18	33.13	5.96	0.60	-0.08
EPS (Diluted)	-0.22	2.94	-0.31	3.31	-0.18	31.85	5.96	0.53	-0.08
EBITDA	40.79M	101.73M	54.41M	133.16M	69.05M	38.01M	238.3M	81.15M	55.17M
EBIT	5.55M	64.32M	37.81M	91.82M	28.71M	-5.72M	221.61M	68.63M	20.8M
Depreciation & Amortization	35.24M	37.41M	43.39M	41.34M	27.97M	43.73M	16.69M	12.52M	11.29M